PIC Therapeutics Employee Directory

Biotechnology ResearchMassachusetts, United States2-10 Employees

PIC Therapeutics is a biotechnology company focused on advancing cancer treatment by modulating RNA translation. Based in Natick, Massachusetts, the firm traces its origins to the foundational work of Harvard Medical School professor Dr. Gerhard Wagner and aims to translate these findings into precision therapeutics that affect oncogene translation. Led by President and CEO Dr. Kathy Bowdish, PIC Therapeutics seeks to selectively disrupt the initiation process that drives oncogene mRNA translation by influencing the Pre-Initiation Complex, with the goal of blocking oncogene protein production across multiple signaling pathways. 

A notable development in 2023 was the appointment of Richard Gedrich as Chief Development Officer. The company aims to address cancer by modulating oncogene translation and seeks collaboration with researchers and biopharmaceutical developers interested in precision therapeutics. With a small team based in Natick, it operates within the biotechnology research sector focused on next-generation cancer interventions.

Sign up for free to view info

Company overview Email format